India
VHB Life Sciences is a pharmaceutical manufacturing company based in India. Since its inception in 1946, the company has established itself as a prominent player in the global market, supplying high-quality branded generic formulations to more than 54 countries worldwide. Specializing in the development and production of parenteral formulations, VHB has an impressive annual capacity of 180 million injectables, adhering to US-FDA/UK-MHRA standards.
The company prides itself on its ultramodern cold storage distribution network and manufacturing facilities, showcasing its commitment to excellence in delivering a wide range of formulations. With a portfolio of over 200 specialty products, VHB has strategically positioned itself in niche markets and boasts a dedicated team of 1000+ professionals with expertise in finished formulations and API.
One of VHB's key strengths lies in its technical expertise in lyophilized and liquid parenterals, including pre-filled syringes. The company's aggressive medico-marketing approach further underscores its commitment to innovation and growth in the healthcare and pharmaceutical industries.
Despite the significant accomplishments and capabilities of VHB Life Sciences, the details about its latest investment and investors are currently not available.
